logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10792310 B1

PDFFull Text
Date of Patent:
Oct. 06, 2020

Filed:

Jul. 17, 2017

Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells

Applicant:

Creative Medical Technologies, Inc., Phoenix, AZ (US);

Inventors:

Thomas Ichim, San Diego, CA (US);

Amit Patel, Salt Lake City, UT (US);

Assignee:

Creative Medical Technologies, Inc., Phoenix, AZ (US);

Attorneys:

Baumgartner Patent Law

Marc Baumgartner

Primary Examiner:

Kevin K Hill

Assistant Examiner:

James Joseph Graber

Int. Cl.
CPC ...
A61K 35/44 (2015.01); A61K 35/28 (2015.01); A61K 31/56 (2006.01); A61K 35/22 (2015.01); A61K 9/00 (2006.01); C12N 5/0775 (2010.01); A61K 31/57 (2006.01); A61K 31/565 (2006.01); A61K 45/06 (2006.01); A61K 35/17 (2015.01); C12N 5/071 (2010.01); A61K 35/51 (2015.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 35/44 (2013.01); A61K 9/0019 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01); A61K 35/17 (2013.01); A61K 35/22 (2013.01); A61K 35/28 (2013.01); A61K 35/51 (2013.01); A61K 45/06 (2013.01); C12N 5/0662 (2013.01); C12N 5/0663 (2013.01); C12N 5/0692 (2013.01); A61K 2035/124 (2013.01); C12N 2320/30 (2013.01); C12N 2501/392 (2013.01);
Abstract

This invention pertains to the field of ovarian aging and premature ovarian failure. Specifically, we herein disclose methods for treating these conditions using endothelial progenitor cells alone or in combination with mesenchymal stem cells. Furthermore, these cell-based therapies can be utilized in combination with estrogen and progesterone receptor ligands to enhance the therapeutic activity of said cells for restoring or maintaining ovarian function and female fertility.

Find Patent Forward Citations

Ichim, Thomas. (2020). Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells (U.S. Patent No. 10792310). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10792310

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…